Trials / Conditions / Arginase I Deficiency
Arginase I Deficiency
4 registered clinical trials studyying Arginase I Deficiency.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | A Study of Safety of Weekly Subcutaneous Pegzilarginase in Subjects With Arginase 1 Deficiency NCT05676853 | Aeglea Biotherapeutics | Phase 3 |
| Completed | Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency NCT03921541 | Aeglea Biotherapeutics | Phase 3 |
| Completed | A Study of AEB1102 (Pegzilarginase) in Patients With Arginase I Deficiency NCT03378531 | Aeglea Biotherapeutics | Phase 2 |
| Completed | A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency NCT02488044 | Aeglea Biotherapeutics | Phase 1 / Phase 2 |